JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
72 hedge funds and large institutions have $195M invested in Jounce Therapeutics, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 9 closing their positions.
Holders
72
Holders Change
+14
Holders Change %
+24.14%
% of All Funds
1.8%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
23
Increased
27
Reduced
16
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–